CLAY B SIEGALL Insider Trading $RARE Ultragenyx Pharmaceutical Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CLAY B SIEGALL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CLAY B SIEGALL. CLAY B SIEGALL is President & CEO in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Mirna Therapeutics, Inc. ($MIRN).

CLAY B SIEGALL in Ultragenyx Pharmaceutical Inc.

Trading Symbol: RARE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CLAY B SIEGALL: Director
Holdings: 18,204 shares
Current Value: $1,327,254
Latest Transaction: Aug 11 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of CLAY B SIEGALL in Ultragenyx Pharmaceutical Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALDR, SGEN, SYBX, RARE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 11 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorOption ExerciseM40.371,59664,4310
Aug 11 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorOption ExerciseM21.0017,500367,5000
Aug 11 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorOption ExerciseM40.375,904238,3441,596
Aug 11 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorSellS85.011,596135,6762,5504.1 K to 2.6 K (-38.49 %)
Aug 11 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorBuyM40.371,59664,4314,1462.6 K to 4.1 K (+62.59 %)
Aug 11 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorSellS85.019,750828,8482,55012.3 K to 2.6 K (-79.27 %)
Aug 11 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorSellS85.5523,4042,002,21212,30035.7 K to 12.3 K (-65.55 %)
Aug 11 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorBuyM21.0017,500367,50035,70418.2 K to 35.7 K (+96.13 %)
Aug 11 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorBuyM40.375,904238,34418,20412.3 K to 18.2 K (+48.00 %)
Jun 30 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorOption ExerciseA76.584,250325,4654,250
Jun 30 2020RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorGrantA0.002,550012,3009.8 K to 12.3 K (+26.15 %)
Jun 13 2019RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorOption ExerciseA58.745,000293,7005,000
Jun 13 2019RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorGrantA0.003,00009,7506.8 K to 9.8 K (+44.44 %)
Jun 20 2018RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorOption ExerciseA80.695,000403,4505,000
Jun 20 2018RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorGrantA0.003,00006,7503.8 K to 6.8 K (+80.00 %)
Jun 22 2017RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorOption ExerciseA65.663,750246,2253,750
Jun 22 2017RAREUltragenyx Pharmac ...SIEGALL CLAY BDirectorGrantA0.001,87503,7501.9 K to 3.8 K (+100.00 %)
Jun 14 2016RAREUltragenyx Pharmac ...SIEGALL CLAY BOption ExerciseA65.853,750246,9383,750
Jun 14 2016RAREUltragenyx Pharmac ...SIEGALL CLAY BGrantA0.001,87501,8750 to 1.9 K
Jun 22 2015RAREUltragenyx Pharmac ...SIEGALL CLAY BOption ExerciseA97.857,500733,8757,500

Page:   1